Carolinas Wealth Consulting LLC Amgen Inc Transaction History

Carolinas Wealth Consulting LLC

$577 Million
Q3 2024

A detailed history of Carolinas Wealth Consulting LLC transactions in Amgen Inc stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 306 shares of AMGN stock, worth $90,126. This represents 0.02% of its overall portfolio holdings.

Number of Shares

306

Previous 401 23.69%

Holding current value

$90,126

Previous $125,000 21.6%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $29,391 - $32,051	-95 Reduced 23.69%	306 $98,000
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $2,364 - $2,873	-9 Reduced 2.2%	401 $125,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $1,613 - $1,947	6 Added 1.49%	410 $116,000
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $2,557 - $2,884	-10 Reduced 2.42%	404 $116,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $164,206 - $203,866	-751 Reduced 64.46%	414 $111,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $73,066 - $86,399	-341 Reduced 22.64%	1,165 $258,000
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $48,544 - $59,168	215 Added 16.65%	1,506 $364,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $26,338 - $33,466	115 Added 9.78%	1,291 $339,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $9,427 - $10,632	42 Added 3.7%	1,176 $265,000
Q2 2022 Aug 16, 2022	SELL	$230.71 - $256.74 $12,689 - $14,120	-55 Reduced 4.63%	1,134 $276,000
Q1 2022 May 17, 2022	SELL	$219.27 - $242.57 $30,917 - $34,202	-141 Reduced 10.6%	1,189 $288,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $65,630 - $75,108	330 Added 33.0%	1,330 $299,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $5,094 - $5,968	24 Added 2.46%	1,000 $213,000
Q2 2021 Aug 17, 2021	SELL	$233.58 - $259.14 $137,578 - $152,633	-589 Reduced 37.64%	976 $238,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $8,432 - $9,826	38 Added 2.49%	1,565 $389,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $53,662 - $63,902	248 Added 19.39%	1,527 $351,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $170,121 - $189,188	725 Added 130.87%	1,279 $325,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $109,586 - $134,477	554 New	554 $131,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.

Account

Carolinas Wealth Consulting LLC Amgen Inc Transaction History